{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:41:56Z","timestamp":1759092116642},"reference-count":25,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,7,11]],"date-time":"2006-07-11T00:00:00Z","timestamp":1152576000000},"content-version":"vor","delay-in-days":6280,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[1989,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The extrinsic fibrinolytic system and its response to cigarette smoking was studied in five healthy male smokers 35\u201345 years old. Tissue plasminogen activator (t\u2010PA) release in response to venous occlusion was intact both at 8:00 A.M. and 3:00 P.M. Acutely smoking two cigarettes neither stimulated fibrinolysis nor changed levels of t\u2010PA or plasminogen activator inhibitors. Functional plasminogen activator inhibitor (PA\u2010I) levels and euglobulin lysis times were higher in the smoking group than in a control group matched for age, sex, and body mass. Antigenic levels of PA\u2010I 1, the PA\u2010I derived from vascular endothelial cells and platelets, were similar in both groups. While smoking did not acutely alter fibrinolysis in chronic smokers, these individuals had a high frequency of abnormal fibrinolysis characterized by high levels of PA\u2010I activity. This abnormality is due to either high specific activity of PA\u2010I 1 or to the presence of other antigenically distinct plasminogen activator inhibitors. Abnormal firbinolysis may be one mechanism contributing to the thrombotic diathesis of cigarette smokers.<\/jats:p>","DOI":"10.1002\/ajh.2830310107","type":"journal-article","created":{"date-parts":[[2007,2,21]],"date-time":"2007-02-21T11:46:19Z","timestamp":1172058379000},"page":"36-40","source":"Crossref","is-referenced-by-count":34,"title":["Abnormal fibrinolysis in healthy male cigarette smokers: Role of plasminogen activator inhibitors"],"prefix":"10.1002","volume":"31","author":[{"given":"William D.","family":"Haire","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan C.","family":"Goldsmith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,7,11]]},"reference":[{"issue":"1","key":"e_1_2_1_2_2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1055\/s-0038-1651064","article-title":"Deficient t\u2010PA release and elevated PA inhibitor levels inpatients with spontaneous or recurrent deep venous thrombosis","volume":"57","author":"Juhan\u2010Vague I","year":"1987","journal-title":"Thromb Haemost"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.290.6480.1453"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198512193132501"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(88)90878-2"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)93050-9"},{"key":"e_1_2_1_7_2","first-page":"1279","volume-title":"Hemostasis and Thrombosis: Basic Principles and Clinical Practice","author":"Colman RW","year":"1987"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(83)90407-3"},{"key":"e_1_2_1_9_2","first-page":"637","article-title":"Effect of antihemophilic factor on one\u2010stage clotting tests","volume":"41","author":"Langdell RD","year":"1953","journal-title":"J Lab Clin Med"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(66)90246-6"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.12.3.215"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1981.tb01421.x"},{"key":"e_1_2_1_13_2","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1182\/blood.V70.5.1645.1645","article-title":"Plasminogen activator inhibitor 1: Development of a radioimmunoassay and observations on its plasma concentration during venous occlusion and after platelet aggregation","volume":"70","author":"Kruithof EKO","year":"1987","journal-title":"Blood"},{"key":"e_1_2_1_14_2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1055\/s-0038-1642561","article-title":"Fibrinolytic and haemostatic responses to desamino\u2010D\u2010arginine vasopressin (DDAVP) administered by intravenous and subcutaneous routes in healthy subjects","volume":"59","author":"MacGregor IR","year":"1988","journal-title":"Thromb Haemost"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1984.tb01195.x"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(86)90209-X"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(87)90264-7"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016348609155174"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.5.5.443"},{"key":"e_1_2_1_20_2","first-page":"339","article-title":"Diurnal variation in tissue plasminogen activator and its rapid inhibitor","volume":"76","author":"Angleton P","year":"1987","journal-title":"Circulation"},{"key":"e_1_2_1_21_2","first-page":"338","article-title":"Major circadian fluctuations of fibrinolytic parameters in relation to the time of onset of myocardial infarction and stroke","volume":"76","author":"Andreotti F","year":"1987","journal-title":"Circulation"},{"key":"e_1_2_1_22_2","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1182\/blood.V70.4.1090.1090","article-title":"Conversion of the active to latent plasminogen activator inhibitor from human endothelial cells","volume":"70","author":"Levin EG","year":"1987","journal-title":"Blood"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V69.2.381.381"},{"key":"e_1_2_1_24_2","first-page":"569","article-title":"A fibrinolytic inhibitor of human alveolar macrophages","volume":"132","author":"Chapman HA","year":"1985","journal-title":"Am Rev Respir Dis"},{"issue":"1","key":"e_1_2_1_25_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-0038-1642556","article-title":"Plasminogen activator inhibitor 1 and plasminogen activator inhibitor 2 in various disease states","volume":"59","author":"Kruithof EKO","year":"1988","journal-title":"Thromb Haemost"},{"issue":"1","key":"e_1_2_1_26_2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1055\/s-0038-1661451","article-title":"A sensitive assay, specific for endothelial cell type plasminogen activator inhibitor in blood plasma","volume":"55","author":"Sprengers ED","year":"1986","journal-title":"Thromb Haemost"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.2830310107","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.2830310107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T02:19:07Z","timestamp":1697941147000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.2830310107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,5]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1989,5]]}},"alternative-id":["10.1002\/ajh.2830310107"],"URL":"https:\/\/doi.org\/10.1002\/ajh.2830310107","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,5]]}}}